Work

High MET amplification level as a resistance mechanism to osimertinib (AZD9291) in a patient that symptomatically responded to crizotinib treatment post-osimertinib progression

Year: 2016

Type: article

Study design: Case Report

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2016.05.015

Authors: Sai-Hong Ignatius Ou, Nikita Agarwal, Siraj M. Ali

Institutions: University of California, Irvine, University of California, Irvine Medical Center, Foundation Medicine (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2462969936

FWCI: 19.45

Cites: 14

Cited by: 148

Related to: 10